(Q80381830)

English

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis

scientific article published on 01 June 2007

Statements

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit